Are Biosimilars Becoming a Key Pillar of Amgen's Growth Story?

Are Biosimilars Becoming a Key Pillar of Amgen's Growth Story?  The Globe and Mail

Summary aggregated from The Globe and Mail's public RSS feed. The full reporting belongs to The Globe and Mail — please read it on their site.